Powerscourt

By Powerscourt on 21/02/2024

Powerscourt Advises Arix Bioscience on its acquisition by RTW Biotech Opportunities

Powerscourt was pleased to support Arix Bioscience, a transatlantic venture capital company focused on biotechnology, through its acquisition by RTW Biotech Opportunities, a UK-listed life science investment fund. 

The combination of Arix’s complementary assets with RTW creates a fund with significant global scale and a solid grounding to make impactful investments in breakthrough technologies at the cutting edge of life sciences. 

The Powerscourt teams, comprising Sarah MacLeod, Pete Lambie, Nicholas Johnson and Molly Ring, provided continual support to Arix for over two years, concluding with robust support and media engagement during the transaction, which was structured as a scheme of reconstruction, through to completion. 

Sarah MacLeod, Director of Healthcare at Powerscourt, said:

“This is a pivotal transaction in the healthcare sector, providing investors with access to a leading specialist life science fund with greater scale and enhanced access to exciting investment opportunities in potentially life-saving innovations

“This transaction consolidates the track record of Powerscourt’s Healthcare team in M&A, following its work last year advising French private equity firm Archimed on its acquisition of Instem, a life science software company”




This rebrand represents our dedication to building a world-class advisory firm with unwavering commitment to excellence for our clients, colleagues, and communities, supporting them to adapt and thrive in an increasingly volatile, uncertain, complex, and ambiguous world. Our new identity recognizes the Firm’s 50- year history and unifies the compelling combination of businesses, skills, and expertise you know from Morrow Sodali, GPS, Di Costa Partners, Nestor Advisors, Gryphon Advisors, Citadel MAGNUS, FrameworkESG, HXE Partners, Powerscourt, Domestique, and Designate. The name derives from the Latin word “Sodalis” meaning companion and aligns with the Firm’s role as a trusted advisor. The pace of change has never been this fast, so we look forward to continuing to provide you with the tools to build stakeholder capital and navigate the complex dynamic of shareholder and wider stakeholder interests.
Discover more at sodali.com
We are thrilled to announce the launch of our new brand – Sodali & Co.
This rebrand represents our dedication to building a world-class advisory firm with unwavering commitment to excellence for our clients, colleagues, and communities, supporting them to adapt and thrive in an increasingly volatile, uncertain, complex, and ambiguous world. Our new identity recognizes the Firm’s 50- year history and unifies the compelling combination of businesses, skills, and expertise you know from Morrow Sodali, GPS, Di Costa Partners, Nestor Advisors, Gryphon Advisors, Citadel MAGNUS, FrameworkESG, HXE Partners, Powerscourt, Domestique, and Designate. The name derives from the Latin word “Sodalis” meaning companion and aligns with the Firm’s role as a trusted advisor. The pace of change has never been this fast, so we look forward to continuing to provide you with the tools to build stakeholder capital and navigate the complex dynamic of shareholder and wider stakeholder interests.
Discover more at sodali.com
We are thrilled to announce the launch of our new brand – Sodali & Co.
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

 MENU